| Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results - MarketWatch (press release) |
|
|
MarketWatch (press release) Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, ... Keryx Biopharmaceuticals Inc (KERX) Posts Quarterly Earnings Results, Misses |